To summarize, our findings suggest that the venlafaxine may offer additional benefit to IBD with coexisting psychological problems, as evidenced by significant improvement in QoL, anxious and depressive symptoms, and the activity of IBD (measured by CDAI, Mayo scores, ESR, CRP, and TNF-α). This evidence concerns the gene CRP and inflammatory bowel disease.